Combined use of clinical pretest probability and D‐dimer test in cancer patients with clinically suspected deep venous thrombosis
- 1 January 2006
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 4 (1) , 52-57
- https://doi.org/10.1111/j.1538-7836.2005.01671.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Deep vein thrombosisThe Lancet, 2005
- Malignancies, Prothrombotic Mutations, and the Risk of Venous ThrombosisJAMA, 2005
- Management of thrombosis in cancer: primary prevention and secondary prophylaxisBritish Journal of Haematology, 2005
- Antithrombotic Therapy for Venous Thromboembolic DiseaseChest, 2004
- Outcomes and Cost of Deep Venous Thrombosis Among Patients With CancerArchives of internal medicine (1960), 2004
- d-Dimer for the Exclusion of Acute Venous Thrombosis and Pulmonary EmbolismAnnals of Internal Medicine, 2004
- Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosisBlood, 2002
- Plasma D-Dimers in the Diagnosis of Venous ThromboembolismArchives of internal medicine (1960), 2002
- Prognosis of Cancers Associated with Venous ThromboembolismNew England Journal of Medicine, 2000
- Incidence of Recurrent Thromboembolic and Bleeding Complications Among Patients With Venous Thromboembolism in Relation to Both Malignancy and Achieved International Normalized Ratio: A Retrospective AnalysisJournal of Clinical Oncology, 2000